CMPI

Checkmate Pharmaceuticals, Inc.CIK 1651431 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for CMPI PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for CMPI

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
BASH ALAN	Chief Executive Officer	2	$0	$0	2022-05-31
Yan Joy	Director	2	$0	$0	2022-05-31
Dolski Robert	Chief Financial Officer	5	$0	$0	2022-05-31
Colabuono Peter	Director	4	$0	$0	2022-05-31
Isacoff Oren	Director	4	$0	$0	2022-05-31
Wooldridge James	Chief Medical Officer	9	$0	$0	2022-05-31
Wigginton Jon Marc	Director	2	$0	$0	2022-05-31
Flaherty Keith T.	Director	4	$0	$0	2022-05-31
Fuhrman Alan	See Remarks	5	$0	$0	2022-05-31
POWELL MICHAEL	Director, 10% Owner	6	$0	$0	2022-05-31
GOODMAN COREY S	10% Owner	2	$0	$1.38M	2022-05-16
venBio Global Strategic Fund II L.P.	10% Owner	9	$0	$4.54M	2022-05-12
venBio Global Strategic GP II, Ltd.	10% Owner	11	$3.00M	$8.51M	2022-05-04
venBio Global Strategic GP II, L.P.	10% Owner	3	$0	$1.35M	2022-04-26
Novo Holdings A/S	10% Owner	6	$7.50M	$23.0K	2022-02-25
Chaudhary Kleem	Chief Business Officer	8	$0	$0	2021-08-04
Labinger Barry	President and CEO	2	$0	$0	2021-08-04
Krieg Arthur M	Chief Scientific Officer	16	$957.5K	$0	2021-06-18
Sofinnova Management IX, L.L.C.	10% Owner	5	$2.00M	$0	2020-08-11
Brennan Karen	Chief Operating Officer	1	$0	$0	2020-08-06

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
BASH ALAN	Chief Executive Officer	D To issuer deriv	2022-05-31	2022-05-31	575,000	—	$0	0	SEC↗
Fuhrman Alan	Director	D To issuer deriv	2022-05-31	2022-05-31	22,736	—	$0	0	SEC↗
Fuhrman Alan	Director	D To issuer deriv	2022-05-31	2022-05-31	246,671	—	$0	0	SEC↗
Fuhrman Alan	Director	D To issuer deriv	2022-05-31	2022-05-31	10,030	—	$0	0	SEC↗
Wigginton Jon Marc	Director	D To issuer deriv	2022-05-31	2022-05-31	20,061	—	$0	0	SEC↗
Wooldridge James	Chief Medical Officer	D To issuer deriv	2022-05-31	2022-05-31	54,600	—	$0	0	SEC↗
Wooldridge James	Chief Medical Officer	D To issuer deriv	2022-05-31	2022-05-31	101,180	—	$0	0	SEC↗
Wooldridge James	Chief Medical Officer	D To issuer deriv	2022-05-31	2022-05-31	27,300	—	$0	0	SEC↗
Wooldridge James	Chief Medical Officer	D To issuer deriv	2022-05-31	2022-05-31	150,818	—	$0	0	SEC↗
Wooldridge James	Chief Medical Officer	D To issuer deriv	2022-05-31	2022-05-31	95,916	—	$0	0	SEC↗
Dolski Robert	Chief Financial Officer	D To issuer deriv	2022-05-31	2022-05-31	101,180	—	$0	0	SEC↗
Dolski Robert	Chief Financial Officer	D To issuer deriv	2022-05-31	2022-05-31	27,300	—	$0	0	SEC↗
Dolski Robert	Chief Financial Officer	D To issuer deriv	2022-05-31	2022-05-31	150,000	—	$0	0	SEC↗
Yan Joy	Director	D To issuer deriv	2022-05-31	2022-05-31	20,061	—	$0	0	SEC↗
Colabuono Peter	Director	D To issuer deriv	2022-05-31	2022-05-31	10,030	—	$0	0	SEC↗
Colabuono Peter	Director	D To issuer deriv	2022-05-31	2022-05-31	20,000	—	$0	0	SEC↗
Isacoff Oren	Director	D To issuer deriv	2022-05-31	2022-05-31	10,030	—	$0	0	SEC↗
Isacoff Oren	Director	D To issuer deriv	2022-05-31	2022-05-31	20,000	—	$0	0	SEC↗
Flaherty Keith T.	Director	D To issuer deriv	2022-05-31	2022-05-31	10,030	—	$0	0	SEC↗
Flaherty Keith T.	Director	D To issuer deriv	2022-05-31	2022-05-31	22,736	—	$0	0	SEC↗
Flaherty Keith T.	Director	D To issuer deriv	2022-05-31	2022-05-31	4,012	—	$0	0	SEC↗
POWELL MICHAEL	Director	D To issuer deriv	2022-05-31	2022-05-31	10,030	—	$0	0	SEC↗
POWELL MICHAEL	Director	D To issuer deriv	2022-05-31	2022-05-31	30,000	—	$0	0	SEC↗
POWELL MICHAEL	Director	D To issuer deriv	2022-05-31	2022-05-31	30,000	—	$0	0	SEC↗
GOODMAN COREY S	10% Owner	S Sale	2022-05-16	2022-05-17	95,800	$10.45	$1.00M	2,155,930	SEC↗
GOODMAN COREY S	10% Owner	S Sale	2022-05-13	2022-05-17	35,850	$10.45	$374.6K	2,251,730	SEC↗
venBio Global Strategic Fund I	10% Owner	S Sale	2022-05-12	2022-05-12	124,525	$10.39	$1.29M	2,287,580	SEC↗
venBio Global Strategic Fund I	10% Owner	S Sale	2022-05-11	2022-05-12	17,700	$10.38	$183.7K	2,412,105	SEC↗
venBio Global Strategic Fund I	10% Owner	S Sale	2022-05-10	2022-05-12	18,676	$10.38	$193.9K	2,429,805	SEC↗
venBio Global Strategic Fund I	10% Owner	S Sale	2022-05-09	2022-05-09	17,600	$10.37	$182.5K	2,448,481	SEC↗
venBio Global Strategic Fund I	10% Owner	S Sale	2022-05-06	2022-05-09	48,334	$10.37	$501.2K	2,466,081	SEC↗
venBio Global Strategic Fund I	10% Owner	S Sale	2022-05-05	2022-05-09	20,743	$10.37	$215.1K	2,514,415	SEC↗
venBio Global Strategic GP II,	10% Owner	S Sale	2022-05-04	2022-05-04	37,500	$10.37	$388.9K	2,535,158	SEC↗
venBio Global Strategic GP II,	10% Owner	S Sale	2022-05-03	2022-05-04	79,475	$10.37	$824.2K	2,572,658	SEC↗
venBio Global Strategic GP II,	10% Owner	S Sale	2022-05-02	2022-05-04	153,700	$10.38	$1.60M	2,652,133	SEC↗
venBio Global Strategic Fund I	10% Owner	S Sale	2022-04-29	2022-04-29	69,230	$10.38	$718.6K	2,805,833	SEC↗
venBio Global Strategic Fund I	10% Owner	S Sale	2022-04-28	2022-04-29	73,400	$10.38	$761.9K	2,875,063	SEC↗
venBio Global Strategic Fund I	10% Owner	S Sale	2022-04-27	2022-04-29	47,396	$10.38	$492.0K	2,948,463	SEC↗
venBio Global Strategic GP II,	10% Owner	S Sale	2022-04-26	2022-04-26	64,683	$10.38	$671.4K	2,995,859	SEC↗
venBio Global Strategic GP II,	10% Owner	S Sale	2022-04-25	2022-04-26	27,668	$10.39	$287.5K	3,060,542	SEC↗
venBio Global Strategic GP II,	10% Owner	S Sale	2022-04-22	2022-04-26	37,430	$10.39	$388.9K	3,088,210	SEC↗
venBio Global Strategic GP II,	10% Owner	S Sale	2022-04-21	2022-04-21	62,200	$10.38	$645.6K	3,125,640	SEC↗
venBio Global Strategic GP II,	10% Owner	S Sale	2022-04-20	2022-04-21	85,611	$10.39	$889.5K	3,187,840	SEC↗
venBio Global Strategic GP II,	10% Owner	S Sale	2022-04-19	2022-04-21	399,923	$10.42	$4.17M	3,273,451	SEC↗
BASH ALAN	Chief Executive Officer	A Award deriv	2022-03-01	2022-03-02	575,000	—	$0	575,000	SEC↗
Novo Holdings A/S	10% Owner	S Sale	2022-02-25	2022-02-25	300	$2.70	$810	2,161,990	SEC↗
Novo Holdings A/S	10% Owner	S Sale	2022-02-24	2022-02-25	5,990	$2.83	$17.0K	2,162,290	SEC↗
Novo Holdings A/S	10% Owner	S Sale	2022-02-23	2022-02-25	1,820	$2.90	$5.3K	2,168,280	SEC↗
Wigginton Jon Marc	Director	A Award deriv	2022-01-30	2022-02-01	20,061	—	$0	20,061	SEC↗
Wooldridge James	Chief Medical Officer	A Award deriv	2022-01-27	2022-01-31	101,180	—	$0	101,180	SEC↗
Dolski Robert	Chief Financial Officer	A Award deriv	2022-01-27	2022-01-31	101,180	—	$0	101,180	SEC↗
Yan Joy	Director	A Award deriv	2021-12-16	2021-12-17	20,061	—	$0	20,061	SEC↗
Fuhrman Alan	See Remarks	A Award deriv	2021-10-27	2021-10-29	246,671	—	$0	246,671	SEC↗
POWELL MICHAEL	Director	A Award deriv	2021-08-09	2021-08-10	30,000	—	$0	30,000	SEC↗
Labinger Barry	President and CEO	A Award deriv	2021-08-04	2021-08-06	85,950	—	$0	85,950	SEC↗
Chaudhary Kleem	Chief Business Officer	A Award deriv	2021-08-04	2021-08-06	27,300	—	$0	27,300	SEC↗
Wooldridge James	Chief Medical Officer	A Award deriv	2021-08-04	2021-08-06	27,300	—	$0	27,300	SEC↗
Dolski Robert	Chief Financial Officer	A Award deriv	2021-08-04	2021-08-06	27,300	—	$0	27,300	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2021-06-18	2021-06-21	7,224	$6.04	$43.6K	815,734	SEC↗
POWELL MICHAEL	Director	A Award deriv	2021-06-16	2021-06-21	10,030	—	$0	10,030	SEC↗
Colabuono Peter	Director	A Award deriv	2021-06-16	2021-06-21	10,030	—	$0	10,030	SEC↗
Isacoff Oren	Director	A Award deriv	2021-06-16	2021-06-21	10,030	—	$0	10,030	SEC↗
Fuhrman Alan	Director	A Award deriv	2021-06-16	2021-06-21	10,030	—	$0	10,030	SEC↗
Flaherty Keith T.	Director	A Award deriv	2021-06-16	2021-06-21	10,030	—	$0	10,030	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2021-06-16	2021-06-17	3,578	$6.18	$22.1K	808,510	SEC↗
Krieg Arthur M	Chief Scientific Officer	J Other	2021-05-28	2021-06-01	68,457	—	$0	0	SEC↗
Krieg Arthur M	Chief Scientific Officer	J Other	2021-05-28	2021-06-01	68,457	—	$0	0	SEC↗
Krieg Arthur M	Chief Scientific Officer	J Other	2021-05-28	2021-06-01	68,457	—	$0	0	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2021-05-18	2021-05-19	25,001	$6.97	$174.3K	804,932	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2021-03-29	2021-03-31	17,468	$10.94	$191.1K	764,179	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2021-03-29	2021-03-31	15,752	$11.40	$179.6K	779,931	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2021-03-26	2021-03-29	3,484	$12.15	$42.3K	746,711	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2021-03-25	2021-03-29	10,036	$12.35	$123.9K	743,227	SEC↗
Wooldridge James	Chief Medical Officer	A Award deriv	2021-03-04	2022-04-28	54,600	—	$0	54,600	SEC↗
Chaudhary Kleem	Chief Business Officer	M Exercise deriv	2021-02-26	2021-03-01	2,000	—	$0	97,508	SEC↗
Chaudhary Kleem	Chief Business Officer	M Exercise	2021-02-26	2021-03-01	2,000	$2.62	$5.2K	8,000	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2021-01-27	2021-01-28	1,701	$13.05	$22.2K	733,191	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2021-01-19	2021-01-21	500	$13.09	$6.5K	731,490	SEC↗
Chaudhary Kleem	Chief Business Officer	M Exercise deriv	2021-01-14	2021-01-15	2,000	—	$0	99,508	SEC↗
Chaudhary Kleem	Chief Business Officer	M Exercise	2021-01-14	2021-01-15	2,000	$2.62	$5.2K	6,000	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2020-12-29	2020-12-31	443	$14.16	$6.3K	730,990	SEC↗
Chaudhary Kleem	Chief Business Officer	M Exercise deriv	2020-12-22	2020-12-23	4,000	—	$0	101,508	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2020-12-22	2020-12-23	5,103	$14.64	$74.7K	730,547	SEC↗
Chaudhary Kleem	Chief Business Officer	M Exercise	2020-12-22	2020-12-23	4,000	$2.62	$10.5K	4,000	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2020-12-16	2020-12-17	4,805	$14.62	$70.2K	725,444	SEC↗
Krieg Arthur M	Chief Scientific Officer	P Buy	2020-12-15	2020-12-17	42	$14.49	$609	720,639	SEC↗
Colabuono Peter	Director	A Award deriv	2020-11-10	2020-11-12	20,000	—	$0	20,000	SEC↗
Isacoff Oren	Director	A Award deriv	2020-11-10	2020-11-12	20,000	—	$0	20,000	SEC↗
POWELL MICHAEL	Director, 10% Owner	A Award deriv	2020-11-10	2020-11-12	30,000	—	$0	30,000	SEC↗
venBio Global Strategic GP II,	10% Owner	C Conversion deriv	2020-08-11	2020-08-12	3,644,624	—	$0	0	SEC↗
venBio Global Strategic GP II,	10% Owner	C Conversion deriv	2020-08-11	2020-08-12	12,500,000	—	$0	0	SEC↗
venBio Global Strategic GP II,	10% Owner	C Conversion deriv	2020-08-11	2020-08-12	8,753,350	—	$0	0	SEC↗
Sofinnova Management IX, L.L.C	10% Owner	C Conversion deriv	2020-08-11	2020-08-12	12,500,000	—	$0	0	SEC↗
Sofinnova Management IX, L.L.C	10% Owner	C Conversion deriv	2020-08-11	2020-08-12	8,753,350	—	$0	0	SEC↗
Sofinnova Management IX, L.L.C	10% Owner	C Conversion deriv	2020-08-11	2020-08-12	3,644,624	—	$0	0	SEC↗
Novo Holdings A/S	10% Owner	C Conversion deriv	2020-08-11	2020-08-13	12,487,512	—	$0	0	SEC↗
venBio Global Strategic GP II,	10% Owner	P Buy	2020-08-11	2020-08-12	200,000	$15.00	$3.00M	3,673,374	SEC↗
venBio Global Strategic GP II,	10% Owner	C Conversion	2020-08-11	2020-08-12	3,473,374	—	$0	3,473,374	SEC↗
Sofinnova Management IX, L.L.C	10% Owner	C Conversion	2020-08-11	2020-08-12	3,473,374	—	$0	3,473,374	SEC↗
Sofinnova Management IX, L.L.C	10% Owner	P Buy	2020-08-11	2020-08-12	133,333	$15.00	$2.00M	3,606,707	SEC↗
Novo Holdings A/S	10% Owner	C Conversion	2020-08-11	2020-08-13	1,670,100	—	$0	1,670,100	SEC↗
Novo Holdings A/S	10% Owner	P Buy	2020-08-11	2020-08-13	500,000	$15.00	$7.50M	2,170,100	SEC↗
Wooldridge James	Chief Medical Officer	A Award deriv	2020-08-06	2020-08-10	150,818	—	$0	150,818	SEC↗
Labinger Barry	President and CEO	A Award deriv	2020-08-06	2020-08-10	445,819	—	$0	445,819	SEC↗
Chaudhary Kleem	Chief Business Officer	A Award deriv	2020-08-06	2020-08-10	141,226	—	$0	141,226	SEC↗
Brennan Karen	Chief Operating Officer	A Award deriv	2020-08-06	2020-08-10	53,496	—	$0	53,496	SEC↗